Pathophysiology and treatment of cardiac amyloidosis.

Pathophysiology and treatment of cardiac amyloidosis.

Item
http://www.wikidata.org/entity/Q38259728
Infiltrative CardiomyopathiesRationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosisDiagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: a systematic review and meta-analysis.Advances in proteomic study of cardiac amyloidosis: progress and potential.Catheter Ablation for Atrial Arrhythmias in Patients With Cardiac Amyloidosis.Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.Cardiac Amyloidosis and its New Clinical Phenotype: Heart Failure with Preserved Ejection Fraction.Recent Advances in Understanding and Managing Cardiomyopathy.Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type Transthyretin.Recurrent Syncope, a Clue in Amyloid Cardiomyopathy.Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosisThree-dimensional Speckle Tracking Echocardiography in Amyloidosis: A New Assessment Method for a Rare Disease
P2860

Pathophysiology and treatment of cardiac amyloidosis.

Item
http://www.wikidata.org/entity/Q38259728
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Pathophysiology and treatment of cardiac amyloidosis.
@en
type
label
Pathophysiology and treatment of cardiac amyloidosis.
@en
prefLabel
Pathophysiology and treatment of cardiac amyloidosis.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Pathophysiology and treatment of cardiac amyloidosis.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698